<DOC>
	<DOCNO>NCT00288613</DOCNO>
	<brief_summary>Purpose The purpose study compare economical impact clinical parameter short daily hemodialysis use NxStageÂ® System One hemodialysis device thrice-weekly conventional in-center dialysis use match cohort US Renal Data System ( USRDS ) database .</brief_summary>
	<brief_title>FREEDOM : Following Rehabilitation , Economics Everyday-Dialysis Outcome Measurements Study</brief_title>
	<detailed_description>In 21st century , nephrologists United States face many challenge include forecast decline physician manpower . Challenges specific hemodialysis ( HD ) include reimbursement constraint , grow shortage nurse major technological advance dialysis equipment . There grow interest alternative dialysis regimen frequency , lack patient incentive self-care dialysis either center home setting . The proposed phase 4 post-marketing study plan explore whether daily HD economically attractive compare thrice weekly HD , improve health-related quality life dialysis adequacy measure . This project unique provide large prospective cohort patient convert daily HD , longitudinal follow ability compare match cohort United States Renal Data Services . This study help develop whether daily dialysis economically attractive use new technology reduce treatment cost decrease hospitalization rate , long-term hope increase life expectancy . All patient option participate Quotidian Dialysis Registry , coordinate Lawson Health Research Institute ( LHRI ) London , Ontario .</detailed_description>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Diagnosis ESRD require dialysis Medicare primary payor ( NOTE : Does include Medicare HMO primary payer ) Candidate daily hemodialysis ( define 6 time per week ) Ability understand willingness sign inform consent statement Health Insurance Portability Accountability Act 1996 ( HIPAA ) compliant authorization statement Current use NxStage System One hemodialysis device Previous enrollment study Current enrollment another investigational drug device trial might impact outcome measure plan study Likelihood survive training period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>ESRD</keyword>
	<keyword>Daily Hemodialysis</keyword>
	<keyword>Hemodialysis</keyword>
	<keyword>Kidney Failure</keyword>
	<keyword>Kidney Disease</keyword>
</DOC>